approach by 3 big pharma's

The part of the announcement below could be interpreted to mean they are talking to 3 of the largest global pharma companies regarding 2 major global interests, HDA and ???? R Sultbutamol maybe. Wording was very good.

The Company further advises that following approach by two major global industry interests, the companys executives have commenced early discussions and meeting initiatives in London this week with three of the largest global pharma and healthcare companies regarding partnering and/or alliance agreements for the Companys Inhalation Drug Delivery Platform.

Still plenty of interest